Abstract 4956
Background
Prospective DPYD genotyping prevents severe fluoropyrimidine-induced toxicity by decreasing initial dosages in DPYD variant allele carriers. However, fluoropyrimidine dosages in chemoradiation therapy are already lower compared to other fluoropyrimidine-containing regimens. It is unknown if recommended dose reductions of pharmacogenetic guidelines are valid for DPYD variant allele carriers receiving fluoropyrimidines in chemoradiation therapy. The aim of this study was to investigate severe toxicity in DPYD variant allele carriers receiving chemoradiation therapy.
Methods
Three databases were used, containing data on patients who received fluoropyrimidine-based chemoradiation therapy. Frequencies of severe (grade ≥3) toxicity in DPYD variant allele carriers (DPYD*2A, DPYD*13, c.2846A>T or c.1236G>A) receiving upfront fluoropyrimidine dose reductions according to current pharmacogenetic dosing guidelines (50 or 75% depending on the variant), and DPYD variant allele carriers receiving full-dose were compared to DPYD wild-type patients receiving standard dose fluoropyrimidines in chemoradiation therapy.
Results
DPYD variant allele carriers treated with standard dosages (N = 34) showed an increased risk of severe gastrointestinal (adjusted OR = 2.58, 95% CI = 1.02-6.53, P = 0.045) or severe haematological (adjusted OR = 4.19, 95% CI = 1.32-13.25, P = 0.015) toxicity compared to wild-type patients (N = 771). DPYD variant allele carriers who received dose reductions (N = 22) showed a comparable frequency of severe gastrointestinal toxicity, but a higher frequency of severe haematological toxicity, compared to wild-type patients. The mean duration of hospitalisation was significantly shorter in DPYD variant allele carriers who received dose reductions compared to DPYD variant allele carriers treated with standard dosages (4 versus 23 days, P = 0.010).
Conclusions
Standard fluoropyrimidine dosages in chemoradiation therapy resulted in an increased risk of severe toxicity in DPYD variant allele carriers. Fluoropyrimidine dose reductions for DPYD variant allele carriers should also be applied in patients receiving chemoradiation therapy.
Clinical trial identification
Legal entity responsible for the study
Leiden University Medical Centre.
Funding
Has not received any funding.
Editorial Acknowledgement
Disclosure
C.A.T.C. Lunenburg: Previously supported by an unrestricted grant from Roche Pharmaceuticals. All other authors have declared no conflicts of interest.
Resources from the same session
1159 - Molecular characterization and search for founding effects in Canarian families with Hereditary Breast and Ovarian Cancer Syndrome
Presenter: Elisenda Llabres Valenti
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3725 - Effect of the polymorphism rs2066844 of the NOD2 gene on colon cancer incidence in a high cardiovascular risk population. Modulation by gender
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3708 - Effect of the polymorphisms rs1476413, rs1801131, rs4846052 and rs6541003 of the MTHFR gene on prostate cancer in a high cardiovascular risk population
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5057 - Association of a genetic variant in cyclin-dependent kinase Inhibitor 2A gene with the increased risk of breast cancer
Presenter: Soodabeh Shahid Sales
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5970 - Investigating the role of HAT protein TIP60 in regulating functional dynamics of nuclear receptor PXR
Presenter: KARISHMA BAKSHI
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1360 - The role of downregulated SIRT3 expression in patients with hepatocellular carcinoma
Presenter: Hanhee Jo
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1634 - Prediction and Intervention of Colorectal Cancer Risk with Artificial Intelligent System
Presenter: Yang Ge
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
4921 - Measuring the Efficiency of Cancer Care in Europe
Presenter: Rikard Althin
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1235 - Circulating cell-free DNA isolated from plasma of mesenteric veins predicts prognosis in stage II colorectal cancer patients
Presenter: Chih-Yung Yang
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5169 - _lonality of uterine carcinosarcoma as a factor of clinical prognosis.
Presenter: Natalia Levitskaya
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract